Tasks:

• You act as Team Leader Rodent Toxicology with 5 direct scientific reports and direct a reproductive toxicology laboratory.
• As Study Director in nonclinical in vivo safety studies (non GLP and GLP) you focus on developmental and reproductive toxicology (DART) studies as well as rodent toxicology studies.
• You provide nonclinical safety expertise in drug development teams and participate in compilation of regulatory documents (e. g. IB, IND, DSUR) and safety assessments.
• A special area of your toxicological expertise will be DART and the regulatory guidance connected to this field, where you support development teams on DART topics.
• You contribute to developing our laboratory in vivo methods in the spirit of the 3R’s.
• Furthermore, you optimize our GLP environment, serve as contact person for our Quality Assurance Unit and prepare the group for internal and authority GLP inspections.
• If adequately qualified, you will participate in the safety evaluation of in licensing candidates.

Requirements:

• Doctoral Degree in Toxicology, Pharmacology, Veterinary Medicine, Biology or a related field
• Several years of toxicological in vivo experience and as a Study Director for nonclinical safety studies under GLP, preferably in the pharmaceutical area or in a CRO
• Good understanding of regulatory guidance for nonclinical development of active pharmaceutical ingredients
• Board Certification in toxicology (ERT, DABT) is a plus. Willingness to prepare for board certification is expected
• Exceptional written and verbal communication skills in English as well as good communication skills in German
• Adept management skills
• Good team working abilities, a high degree of self motivation and a proactive approach to work

 

Benefits:

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Boehringer Ingelheim is an equal opportunity employer who takes pride in maintaining a diverse and inclusive workplace. We embrace all aspects of diversity and inclusion which benefit our employees, patients and communities. We look forward to receiving your online application!

Original Offer:

Source: http://www.jobstairs.de/stellenangebot-team-leader-rodent-toxicology-fm-boehringer-88397-biberach--1111892_101.html